Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab Biosimilar.

Jentzer, Alexandre

Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab Biosimilar. [electronic resource] - Therapeutic drug monitoring 12 2018 - 749-753 p. digital

Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

1536-3694

10.1097/FTD.0000000000000565 doi


Biosimilar Pharmaceuticals--blood
Drug Monitoring--methods
Humans
Immunoassay
Infliximab--blood